Approval · Notice of Compliance 7382 · 2005
XENICAL: Notice of Compliance 7382
Issued September 16, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7382
- Date
- September 16, 2005
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: for use in the obesity management of adolescent patients aged 12 to 16 years
- Therapeutic class
- Anti-obesity agent, gastrointestinal lipase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XENICAL | Not yet assigned | — |
Medicinal ingredients
- ORLISTAT 120 MG per CAP